ArticleJAC-antimicrobial resistance2022
Antibiotic susceptibility patterns of viridans group streptococci isolates in the United States from 2010 to 2020.
Article in JAC-antimicrobial resistance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The First Case ofMedicina (Kaunas, Lithuania) · 2024Pooled it
- Levofloxacin-Resistant Streptococcus gordonii Infective Endocarditis in an Elderly Patient: A Case Report.Cureus · 2026Article
- Knowledge Deficits Among Community Pharmacists May Drive Antibiotic Resistance in Rural Areas: Evidence from Southern Jordan.Antibiotics (Basel, Switzerland) · 2025Article
- Genomic identification and characterization of Streptococcus oralis group that causes intraamniotic infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Article
- No Stone Left Unturned: A Rare Case of Viridans Strep Bacteremia Secondary to Choledocholithiasis.Cureus · 2025Article
- A Septicemic Child due to a Novel Streptococcal Species,Case reports in infectious diseases · 2025Article
- High prevalence of antibiotic resistance ofJournal of oral microbiology · 2025Article
- Identification and characterisation of carbapenem-resistantNew microbes and new infections · 2024Article
- Low penicillin susceptibility inMicrobiology spectrum · 2024Article
- Population genomics of Streptococcus mitis in UK and Ireland bloodstream infection and infective endocarditis cases.Nature communications · 2024Article
- Molecular Genetic Analysis of Perioperative Colonization by Infection-Related Microorganisms in Patients Receiving Intraoral Microvascular Grafts.Journal of clinical medicine · 2024Article
- Recent development and fighting strategies for lincosamide antibiotic resistance.Clinical microbiology reviews · 2024Review
- Impact of Pericoronary Microbiota Composition on Course of Recovery after Third Molar Alveotomy.Life (Basel, Switzerland) · 2024Article
- Clinical isolates ofAntimicrobial agents and chemotherapy · 2024Article
- Streptococcus taonis sp. nov., a novel bacterial species isolated from a blood culture of a patient.Archives of microbiology · 2024Article
- Microbiological Epidemiology of Invasive Infections Due to Non-Beta-Hemolytic Streptococci, France, 2021.Microbiology spectrum · 2023Article
- Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitisAntimicrobial agents and chemotherapy · 2023Article
- An Overview of Macrolide Resistance in Streptococci: Prevalence, Mobile Elements and Dynamics.Microorganisms · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Viridans group streptococci (VGS) are typically part of the commensal flora but can also cause severe invasive diseases such as infective endocarditis. There are limited data available showing antibiotic susceptibility over time for VGS. Objectives: To evaluate antibiotic susceptibility trends in VGS over time. Methods: Results: A total of 14 981 VGS isolates were included of which 19.5%, 0.7% and 79.8% were Conclusions: Susceptibility rates for some clinically relevant antibiotics declined between 2010 and 2020. This worrisome trend highlights the need to improve antimicrobial stewardship efforts to limit unnecessary antibiotic use and preserve empirical treatment options.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.